JOSE MANUEL
VALDIVIELSO REVILLA
CON
![Foto de JOSE MANUEL](/img/nophoto.png)
![Foto de Karolinska Institute](/img/noimage_org.png)
Karolinska Institute
Estocolmo, SueciaPublicaciones en colaboración con investigadores/as de Karolinska Institute (6)
2023
-
Calprotectin is a contributor to and potential therapeutic target for vascular calcification in chronic kidney disease
Science translational medicine, Vol. 15, Núm. 712, pp. eabn5939
-
Estimated Glomerular Filtration Rate, Albuminuria, and Adverse Outcomes: An Individual-Participant Data Meta-Analysis
JAMA, Vol. 330, Núm. 13, pp. 1266-1277
-
Including measures of chronic kidney disease to improve cardiovascular risk prediction by SCORE2 and SCORE2-OP
European Journal of Preventive Cardiology, Vol. 30, Núm. 1, pp. 8-16
-
Major cardiovascular events and subsequent risk of kidney failure with replacement therapy: a CKD Prognosis Consortium study
European heart journal, Vol. 44, Núm. 13, pp. 1157-1166